Immunotherapy for Infectious Diseases

Dendritic Cells 113
mouse pneumonitis induced by vaccination with live organisms correlates with early
granulocyte-macrophage colony-stimulating factor and interleukin-12 production and with
dendritic cell-like maturation. Infect Immun 1999; 67:1606–1613.
61. Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge
between a CD4� T-helper and a T-killer cell. Nature 1998; 393:474–478.
62. Rehermann B, Fowler P, Sidney J, et al. The cytotoxic T lymphocyte response to multiple
hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med
1995; 181:1047–1058.
63. Shimizu Y, Guidotti LG, Fowler P, Chisari FV. Dendritic cell immunization breaks cytotoxic
T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol 1998;
161:4520–4529.
64. Sieling PA, Jullien D, Dahlem M, et al. CD1 expression by dendritic cells in human leprosy
lesions: correlation with effective host immunity. J Immunol 1999; 162:1851–1858.
65. Stenger S, Niazi KR, Modlin RL. Down-regulation of CD1 on antigen-presenting cells by
infection with Mycobacterium tuberculosis. J Immunol 1998; 161:3582–3588.
66. Reis e Sousa C, Sher A, Kaye P. The role of dendritic cells in the induction and regulation
of immunity to microbial infection. Curr Opin Immunol 1999; 11:392–399.
67. Barral A, Carvalho JS, Barral-Netto M, et al. Treatment of visceral leishmaniasis with
pentavalent antimony and interferon gamma. N Engl J Med 1990; 322:16.
68. Romani L, Puccetti P, Bistoni F. Interleukin-12 in infectious diseases. Clin Microbiol Rev
1997; 10:611.
69. Nathan C. Interferon and inflammation. In: Gallin JI, Goldstein IM, Snyderman R (eds).
Inflammation. New York: Raven, 1992, p. 265.
70. Newport MJ, Huxley CM, Huston S. A mutation in the interferon-�-receptor gene and susceptibility
to mycobacterial infection. N Engl J Med 1996; 335:1941.
71. Cocchi F, Devico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of
RANTES, MIP-1� MIP-1� as the major HIV-suppressive factors produced by CD8�
T cells. Science 1995; 270:1811–1815.
72. Papadopoulos EJ, Sassetti C, Saeki H, et al. Fractalkine, a CX3C chemokine, is expressed
by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol 1999;
29:2551–2559.
73. Austyn JM, Larsen CP. Migration patterns of dendritic leukocytes. Implications for transplantation.
Transplantation 1990; 49:1–7.
74. Robert C, Fuhlbrigge RC, Kieffer JD, et al. Interaction of dendritic cells with skin endothelium:
a new perspective on immunosurveillance. J Exp Med 1999; 189:627–636.
75. Greaves DR, Wang W, Dairaghi DJ, et al. CCR6, a CC chemokine receptor that interacts
with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic
cells. J Exp Med 1997; 186:837–844.
76. Sozzani S, Allavena P, D’Amico G. Cutting edge: differential regulation of chemokine
receptors during dendritic cell maturation: a model for their trafficking properties. J
Immunol 1998; 161:1083–1086.
77. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells
and induce class I-restricted CTLs. Nature 1998; 392:86–89.
78. Svensson M, Stockinger B, Wick MJ. Bone marrow-derived dendritic cells can process
bacteria for MHC-I and MHC-II presentation to T cells. J Immunol 1997; 158:4229–4236.
79. Pure E, Inaba K, Crowley MT, et al. Antigen processing by epidermal Langerhans cells
correlates with the level of biosynthesis of major histocompatibility complex class II molecules
and expression of invariant chain. J Exp Med 1990; 172:1459–1469.
80. Dieu MC, Vanbervliet, B, Vicari A, et al. Selective recruitment of immature and mature
dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med
1998; 188:373–386.
81. Chan VW, Kothakota S, Rohan MC, et al. Secondary lymphoid-tissue chemokine (SLC)